Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Many 340B Providers May Not Pass On Discounts Through Contract Pharmacies – GAO

Executive Summary

House Energy and Commerce Committee releases US Government Accountability Office analysis of 340B contract pharmacies.

You may also be interested in...



340B Hospitals Could See Audits On Use Of Drug Price Savings Under Biden Administration Proposal

Legislation would be needed and will be complicated to develop. While the effectiveness of existing audits has been question by a federal government watchdog, the proposal in Biden’s budget document suggests the administration has some sympathy with drug sponsors’ position in the ongoing fight over the 340B drug discount program.

340B Fight: Lilly ‘Disagrees’ With HHS Advisory Stating Discounts To Contract Pharmacies Are Required

Lilly will not change its 340B discount restrictions in light of the advisory, which was released after HHS was sued by hospitals and other groups seeking a regulatory response against pharma actions.

Lilly Bars Contract Pharmacies From 340B Discounts Despite HRSA Guidance

Distribution limits for Cialis prompts concerns among 340B-eligible providers that Lilly will impose similar restrictions for additional products and that other manufacturers may follow suit.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS123392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel